ArticleNucleic acids research2026
Optimal gene panel selection for targeted spatial transcriptomics experiments.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Spatial transcriptomics analysis is a powerful approach for dissecting the structure of tissue microenvironment and uncovering the mechanism of cell-cell communications. However, existing technologies are limited by either spatial resolution or gene coverage. Most single-cell-resolution technologies target only a few hundred preselected genes, whose choice plays an important role in the overall analysis. It remains a challenge to optimally design a gene panel to maximize the utility of spatial transcriptomics profiling. To fill this gap, we introduce a novel method, named ReconST, to automatically design optimal gene panels for spatial transcriptomics profiling. ReconST leverages information from existing scRNA-seq data and identifies the optimal subset of genes by using a gated autoencoder. By using a high-coverage mouse brain MERFISH dataset and a fetal lung dataset as the reference benchmarks, we showed that ReconST outperforms existing methods in terms of reconstruction accuracy, spatial pattern preservation, and computing efficiency. As such, ReconST provides a useful and generally applicable tool for optimal gene panel design, which in turn can significantly enhance the utility of spatial transcriptomics profiling in a wide range of biomedical investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.